Clinic IT Provider Supply Chain 
Permanente Medicine
APRIL 22, 2025
Many Permanente physicians and physician leaders, including Ramin Davidoff, MD, co-CEO of The Permanente Federation, could be found at shelters coordinating the response and providing care or support for people of the affected communities.
The Medical Futurist
JUNE 17, 2025
Artificial intelligence Already, dentists employ software to get insights into clinical decision-making, but AI is changing the face of dentistry, just like it is in many other fields. Smart toothbrush While AI helps dental professionals provide better treatments, smart toothbrushes enable all of us to take better care of our teeth.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
JULY 5, 2023
Under section 503B, drugs compounded by an FDA-registered outsourcing facility under the supervision of a licensed pharmacist can qualify for exemptions from FDA approval, labeling with adequate directions for use, and certain drug supply chain security requirements, subject to specific conditions. See 21 U.S.C. Draft Guidance III.B.2(e)
My Green Doctor
MAY 3, 2025
The breadth of services provided by modern day medicine is profound. Dilating and anesthetic eye drops are used routinely to treat patients in most ophthalmology clinics. The standard of care worldwide in clinics is to use multidose eyedrop bottles — meaning there is enough medicine one bottle to treat many patients.
California Academy of Family Physicians (CAFP)
MAY 14, 2025
However, for individuals who do not qualify for federal Medicaid funding—such as most undocumented immigrants—the federal government does not provide matching funds, even when those individuals meet income eligibility requirements. The May revision proposes eliminating and suspending much of this funding.
The Medical Futurist
MAY 18, 2025
Clinical use is already accepted, new FDA approvals and new trials are underway targeting new niches, like pediatric surgeries. They have started a large-scale clinical trial involving 10,000 patients, expected to last two years, with plans to obtain CE marking by the end of 2024. But there is undoubtedly impressive progress.
FDA Law Blog
JANUARY 22, 2024
Drug Supply Chain. Recalls, warning letters to online pharmacies, and drug-related import alerts were key tools for OC’s efforts to safeguard the drug supply chain from adulterated products over the prior fiscal year. Clinical Trials. Of course, CDER is a massive organization and OC doesn’t do its work alone.
Expert insights. Personalized for you.
52 
Let's personalize your content